Please Wait...

Molecular Marker Lab

Specialized biomarker services backed by unrivalled scientific expertise, fully validated technology and the highest quality standard.

Molecular Marker Lab - Highly Specialized Biomarker Services for Clinical Trials

Bioclinica Lab is a highly specialized service provider of biochemical marker analysis to the pharmaceutical and biotech industries. Our extensive panel of validated biomarkers serve as surrogate endpoints in support of global, multi-site, clinical trials – from phase I to IV – across a wide range of therapeutic areas. With over 15 years of experience, over 400 clinical trials supported, and over 1 million samples analyzed, we are committed to providing quality services for your clinical study.

BIOMARKER MENU

View our complete list of validated Biomarker assays.
LEARN MORE

BIOMARKER ANALYSIS

Automated methods for Biomarker detection and analysis.
LEARN MORE

CLINICAL LAB SERVICES

In house scientific and technical expertise.
LEARN MORE

QUALITY ASSURANCE

Rigorous QA and CAP accreditation.
LEARN MORE

ADDITIONAL RESOURCES

Biomarker Menu

Download MENU

Molecular Marker Laboratory Services

Download Brochure

Alzheimer's Disease Biomarker Lab Expertise

Download Info Sheet

Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

https://t.co/UZQTot9ovJ
bioclinica (18 hours ago)
RT @Xtalks: When is Central Imaging Needed in #ClinicalTrials? @bioclinica https://t.co/fYGvqU46TI
bioclinica (18 hours ago)
RT @phillytechnews: 11/7: BioClinica, USA Technologies buy California firms ; First Round names female general partner https://t.co/MAvm6…
bioclinica (18 hours ago)
RT @eClinical_Jen: Content from the FDA Webinar on Study Data Technical Conformance Guidelines is here: https://t.co/14eepSOR7b #ITTX17
bioclinica (18 hours ago)
RT @CenterWatch: .@US_FDA approves first #digital pill with sensor to track #patients adherence, https://t.co/XaEctKIFRx
bioclinica (18 hours ago)
RT @RAPSorg: Could you use a mid-week laugh? Many #regulatory pros will appreciate this one, courtesy of @CharlesTam https://t.co/8WxeftiCPv
bioclinica (18 hours ago)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen
Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices